PRVB News | Stock Alarm Pro

Atlas News Feed Alerts PortfolioEconomy Movers Regime Earnings Updates

PRVB(PRVB)

PRVB

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Stock Alarm Pro

Real-time monitoring, screening, and research for professional investors and financial advisors.

support@stockalarm.io

Product

Screener
Chart Studio
Alerts
Institutional
Atlas

Company

About
For advisors
Blog
Press
Contact

© 2026 Stock Alarm, LLC, a product of Center Mark Capital, LLC. Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

Home Screener Alerts

PRVB 4 articles

Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio

marketwatch.com·Mar 13

Sanofi To Buy Provention Bio In $2.9 Billion Deal (SNY) (PRVB)

pulse2.com·Mar 13

Sanofi to buy Provention Bio in deal worth $2.9 billion

marketwatch.com·Mar 13

Provention Bio gets FDA approval for treatment that can delay onset of Type 1 diabetes

marketwatch.com·Nov 18

PRVB(PRVB)

$24.98—

PRVB(PRVB)

NASDAQ

$24.98—